Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse events

Redenšek Trampuž, Sara (author), Kristanc, Tilen (author), Blagus, Tanja (author), Trošt, Maja (author), Dolžan, Vita (author)

Vitamin D is a lipid-soluble molecule and an important transcriptional regulator in many tissues and organs, including the brain. Its role has been demonstrated also in Parkinson’s disease (PD) pathogenesis. Vitamin D receptor (VDR) is responsible for the initiation of vitamin D signaling cascade. The aim of this study was to assess the associations of VDR genetic variability with PD risk and different PD-related phenotypes. We genotyped 231 well characterized PD patients and 161 healthy blood donors for six VDR single nucleotide polymorphisms, namely rs739837, rs4516035, rs11568820, rs731236, rs2228570, and rs1544410. We observed that VDR rs2228570 is associated with PD risk (p < 0.001). Additionally, we observed associations of specific VDR genotypes with adverse events of dopaminergic treatment. VDR rs1544410 (GG vs. GA + AA: p = 0.005; GG vs. GA: p = 0.009) was associated with the occurrence of visual hallucinations and VDR rs739837 (TT vs. GG: p = 0.036), rs731236 (TT vs. TC + CC: p = 0.011; TT vs. TC: p = 0.028; TT vs. CC: p = 0.035), and rs1544410 (GG vs. GA: p = 0.014) with the occurrence of orthostatic hypotension. We believe that the reported study may support personalized approach to PD treatment, especially in terms of monitoring vitamin D level and vitamin D supplementation in patients with high risk VDR genotypes.

• Language: English
• Keywords: vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism
• Work type: Article
• Typology: 1.01 - Original Scientific Article
• Organization: MF - Faculty of Medicine
• Publication status: Published
• Publication version: Version of Record
• Year: 2022
• Number of pages: 9 str.
• Numbering: Vol. 14, art. 853277
• PID: 20.500.12556/RUL-145377
• UDC: 616.8
• ISSN on article: 1663-4365
• DOI: 10.3389/fnagi.2022.853277
• COBISS.SI-ID: 101668611
• Publication date in RUL: 19.04.2023

REDENŠEK TRAMPUŽ, Sara, KRISTANC, Tilen, BLAGUS, Tanja, TROŠT, Maja and DOLŽAN, Vita, 2022, Genetic variability of the vitamin D receptor affects susceptibility to Parkinson’s disease and dopaminergic treatment adverse events. Frontiers in aging neuroscience [online]. 2022. Vol. 14,  853277. [Accessed 7 April 2025]. DOI 10.3389/fnagi.2022.853277. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=145377

Record is a part of a journal

• Title: Frontiers in aging neuroscience
• Shortened title: Front. aging neurosci.
• Publisher: Frontiers Media
• ISSN: 1663-4365
• COBISS.SI-ID: 20576008

Licences

• License: CC BY 4.0, Creative Commons Attribution 4.0 International
• Link: http://creativecommons.org/licenses/by/4.0/
• Description: This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

• Language: Slovenian
• Keywords: nevrologija, Parkinsonova bolezen, receptor vitamina D, nevroznanost

Projects

• Funder: ARRS - Slovenian Research Agency
• Project number: P1-0170
• Name: Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku